OOIR: Observatory of International Research

Papers

(The median citation count of Current Opinion in Hematology is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)

Article	Citations
Posttransplant cyclophosphamide: a universal graft versus host disease prophylaxis	27
Novel blood derived hemostatic agents for bleeding therapy and prophylaxis	26
Novel immune directed therapies in myelodysplastic syndromes and acute myeloid leukemia	23
Deficits in our understanding of natural killer cell development in mouse and human	23
Heme- and iron-activated macrophages in sickle cell disease: an updated perspective	22
Interferon regulatory factor-8-dependent innate immune alarm senses GATA2 deficiency to alter hematopoietic differentiation and function	19
Disparities in acute myeloid leukemia treatments and outcomes	18
Adenosine signaling in promoting the balance between erythropoiesis and myelopoiesis	18
Megakaryocytes as mitochondria factories: potential donors for mitochondria transplantation	18
Mesenchymal stromal cells: an update	18
Developmental regulation of primitive erythropoiesis	18
Limitations of rituximab in treating primary immune thrombocytopenia and the therapeutic potentials of alternatives	17
Unraveling lipid metabolism for acute myeloid leukemia therapy	16
The impact of obesity-induced inflammation on clonal hematopoiesis	16
Platelet lifespan and mechanisms for clearance	16
Editorial introductions	15
Humanized murine models of platelet function	13
Multifaceted roles of CRISPR technology in blood cancer research	13
Shared host, distinct invaders: metabolomic footprints of plasmodium and babesia in host red cells	12
High-throughput genotyping tools for red blood cell antigens	11
Advances on the genetic basis of red cell membrane disorders	10
Editorial introduction	10
Haematopoietic stem cell quiescence exposed using mitochondrial membrane potential	10
Hemostatic abnormalities in acute promyelocytic leukemia: clinical implications and mechanisms	10
Targeting hemostatic enzymes: from mechanistic insights to therapeutic frontiers	9

Red cells: not only hemoglobin – plasma membranes are also of paramount importance	8
Signaling mechanisms and cis-regulatory control of Samd14 in erythroid regeneration	8
Editorial introductions	8
Tissue factor pathway inhibitor – cofactor-dependent regulation of the initiation of coagulation	8
Understanding and targeting erythroid progenitor cells for effective cancer therapy	8
Cellular contributions to the pathogenesis of anti-platelet factor 4 disorders	8
Venous thromboembolism: diagnostic advances and unaddressed challenges in management	7
Translation defects in ribosomopathies	7
Current Opinion in Hematology	7
Platelets in vascular inflammation: fire-fighters or pyromaniacs?	7
Modelling arterial thrombus formation in vitro	7
The immunology of PF4 polyanion interactions	7
Editorial introductions	7
Update on preclinical and clinical efforts on ex-vivo expansion of hematopoietic stem and progenitor cells	7
Measurement of tissue factor-positive extracellular vesicles in plasma: strengths and weaknesses of current methods	7
Immunomodulatory roles of red blood cells	6
Chediak-Higashi syndrome	6
Platelets and platelet–leukocyte interactions in infectious diseases	6
Models to study myelodysplastic syndrome and acute myeloid leukaemia	6
Red blood cell changes due to cancer and cancer treatments: a narrative review	6
PROTACs in platelets: emerging antithrombotic strategies and future perspectives	6
Editorial introduction	6
The state of prediction models in hematologic disease: a worrisome assessment	6
A role of platelet C-type lectin-like receptor-2 and its ligand podoplanin in vascular biology	6
Challenges and opportunities in shared care for international patients treated with cellular therapy for nonmalignant disease	6
Platelet transfusion	5
Editorial introductions	5
The congenital dyserythropoieitic anemias: genetics and pathophysiology	5
Switching and increasing prophylaxis regimen with a genetically recombinant fusion of coagulation factor IX and albumin in haemophilia B: a case report	5
Platelet mitochondria: the mighty few	5
No time to die? Intrinsic apoptosis signaling in hematopoietic stem and progenitor cells and therapeutic implications	5
Hyperviscosity syndromes; hemorheology for physicians and the use of microfluidic devices	5
Azacitidine maintenance in AML post induction and posttransplant	5
The fulfilled promise and unmet potential of umbilical cord blood	5
Recent advances in factor XII structure and function	5
Novel approaches to measure transfusion effectiveness	5
Epigenetics of hematopoietic stem cell aging	5
Donor selection in allogeneic stem cell transplantation	4
Proteomic perspectives on platelet reactivity: towards precision thrombosis research	4
Germline DDX41 mutations in myeloid neoplasms: the current clinical and molecular understanding	4
Alteration of interleukin-10-producing Type 1 regulatory cells in autoimmune diseases	4
Editorial introduction	4
Macrocytic anemias	4
Age-related micro-environmental changes as drivers of clonal hematopoiesis	4
Hematopoietic stem cell collection for sickle cell disease gene therapy	4
Red cell extracellular vesicles and coagulation activation pathways	4
Editorial introduction	4
Proteome remodeling and organelle clearance in mammalian terminal erythropoiesis	4
The impact of prenatal inflammation on hematopoietic development	4
Crosstalk between terminal erythropoiesis and granulopoiesis within their common niche: the erythromyeloblastic island	4

Editorial introduction	4
Pediatric acute myeloid leukemia – novel approaches	3
Role of ATP-dependent chromatin remodelers in hematopoietic stem and progenitor cell maintenance	3
Immunologic effects of red blood cell and platelet transfusions in neonates	3
Direct megakaryopoiesis	3
The role of stem cell transplantation in the modern management of multiple myeloma	3
Iron status of blood donors	3
Editorial introductions	3
Emerging functional microfluidic assays for the study of thromboinflammation in sickle cell disease	3
Platelet Fc gamma RIIA: time to go beyond the unknown	3
Scoring systems to predict thrombotic complications in solid tumor patients	3
N6-methyladenosine in hematological malignancies: a concise review	3
The invisible string of coagulation, complement, iron, and inflammation in sickle cell disease	3
Advances in chimeric antigen receptor-T therapies to target tumor resistance in B-cell malignancies	3
Histological differences among thrombi in thrombotic diseases	2
The role of hematopoiesis in bone repair: an update	2
Fibrin structure, viscoelasticity and lysis face the interplay of biorelevant polyions	2
Pas de deux: the coordinated coupling of erythroid differentiation with the cell cycle	2
microRNAs and thrombo-inflammation: relationship in sight	2
Editorial introduction	2
New molecules in the therapy of chronic graft-versus-host disease	2
Editorial Introductions	2
The interplay between physical and mental health and its impact on outcomes for hemopoietic stem cell transplant patients	2
Circulating endothelial cells in pathophysiology	2
Inflammation and bone marrow fibrosis: novel immunotherapeutic targets	2
The new metabolic needs of hematopoietic stem cells	2
PIEZO1, sensing the touch during erythropoiesis	2
Factor XI as a therapeutic target in neuroinflammatory disease	2
Chimeric antigen receptor T-cell therapy in acute myeloid leukemia	2
Platelet lipidomics and de novo lipogenesis: impact on health and disease	2
Hidden behind thromboinflammation: revealing the roles of von Willebrand factor in sickle cell disease pathophysiology	2
Platelet mechanosensing as key to understanding platelet function	2
Editorial introduction	2
Clonal hematopoiesis of indeterminate potential: recent developments and perspectives	2